preliminari
studi
conduct
determin
cellular
immun
statu
neonat
colostrumdepriv
calv
follow
inocul
either
attenu
virul
bovin
coronaviru
bcv
uninfect
calv
serv
control
determin
intestin
system
cellular
immun
statu
perform
mhcrestrict
cytotox
lymphocyt
ctl
assay
mesenter
lymphocyt
enumer
cell
subset
peripher
blood
lymphocyt
examin
histopatholog
alter
mesenter
lymph
node
gutassoci
lymphoid
tissu
target
cell
ctl
assay
autolog
testicular
cell
effector
cell
mesenter
lymphocyt
calv
infect
bcv
appreci
specif
lysi
observ
group
calv
indic
absenc
demonstr
ctl
respons
ct
popul
sever
depress
calf
inocul
virul
viru
inocul
either
attenu
viru
placebo
mesenter
lymph
node
peyer
patch
calv
inocul
virul
viru
show
sever
deplet
lymphocyt
calv
develop
intestin
antibodi
respons
acut
phase
infect
week
infect
immunosuppress
later
stage
infect
une
prrliminair
conduit
pour
ermin
le
statut
immunitair
de
veaux
nouveaunti
priv
de
colostrum
et
subiss
une
inocul
dun
coronaviru
bovin
bvc
soit
virul
soit
attrnur
le
veaux
non
infect
ont
servi
de
trmoin
pour
ermin
le
statut
immunitair
cellulair
systrmiqu
et
intestin
mi
au
point
un
test
de
lymphotoxicit
ctl
efficac
sur
le
lymphocyt
entrriqu
aussi
la
souspopul
cellulair
parmi
le
lymphocyt
du
sang
prriphrriqu
et
le
altrrat
histopathologiqu
touchant
le
noeud
lymphatiqu
entrriqu
et
le
tissu
lymphoid
de
drainag
associr
le
cellul
cibl
pour
le
test
ctl
de
cellul
autologiqu
de
testicul
et
le
cellul
effectric
dtaient
le
lymphocyt
de
veaux
infectr
par
le
bcv
quelqu
soit
le
group
de
veaux
aucun
lyse
sprcifiqu
signif
n
observr
indiqu
labsenc
de
rrpons
au
ctl
alor
que
veaux
inocul
avec
le
viru
virul
pr
entaient
une
drpression
de
popul
tct
ce
n
ait
pa
le
ca
chez
ceux
inoculd
avec
le
viru
ou
le
placebo
le
noeud
lymphatiqu
entrriqu
et
le
plaqu
de
peyer
de
veaux
ayant
requ
le
viru
virul
montraient
une
drplrtion
marqur
en
lymphocyt
ce
veaux
ont
de
rrpons
en
anticorp
intestinaux
lot
de
la
phase
aigfi
de
linfect
une
semain
aprr
linocul
mai
immunodrprimr
par
la
suit
bovin
coronaviru
bcv
import
caus
scour
calv
month
age
infect
bcv
calv
becom
weak
dehydr
lose
weight
author
correspond
may
die
mortal
rate
bcvinfect
calv
approx
uncompl
case
secondari
infect
calv
infect
bcv
commonli
document
literatur
coronaviru
enter
often
associ
rotaviru
diarrheal
agent
mani
case
calf
scour
accompani
pneumonia
suitabl
vaccin
avail
control
scour
caus
bcv
although
one
market
report
mucos
humor
immun
bcvinfect
calv
avail
role
cell
mediat
immun
cmi
respons
bcv
infect
known
studi
undertaken
evalu
cellular
immun
statu
calv
infect
either
virul
attenu
bcv
examin
cytotox
lymphocyt
ctl
activ
mesenter
lymphocyt
assess
cell
subset
alter
peripher
blood
leukocyt
calv
histopatholog
alter
gutassoci
lymphoid
tissu
galt
calv
also
examin
male
colostrumdepriv
newborn
calv
use
experi
obtain
dairi
barn
univers
minnesota
transfer
isol
facil
immedi
birth
hous
individu
strict
quarantin
procedur
follow
daili
dose
trimethoprim
sulfadiazin
tribrissen
cooper
anim
health
kansa
citi
kan
ceftiofur
sodium
naxcel
upjohn
compani
kalamazoo
mich
given
calv
calv
use
experi
colostrumdepriv
unvaccin
immun
statu
calv
could
studi
independ
matern
vaccin
contribut
attenu
bcv
mebu
strain
undergon
passag
pig
kidney
cell
line
given
addit
passag
human
lung
carcinoma
cell
line
virul
pneumoenter
isol
bcv
minnesota
isol
deriv
bovin
fecal
sampl
submit
minnesota
veterinari
diagnost
laboratori
univers
minnesota
st
paul
minn
sampl
contain
bcv
determin
electron
microscopi
free
bovin
viru
diarrhea
bvd
viru
determin
inocul
cell
cultur
stain
fluorescein
conjug
antibvd
igg
inocul
calv
isol
consist
produc
sever
diarrhea
malabsorpt
pneumonia
calv
infect
oral
day
age
two
calv
calv
inocul
attenu
bcv
three
calv
calv
virul
bcv
one
calf
calf
natur
infect
bcv
three
calv
calv
uninfect
control
calv
attenu
virusinocul
calf
uninfect
control
calf
virul
virusinocul
calf
respect
studi
subset
alter
peripher
blood
laparotomi
procedur
describ
previous
studi
cell
mediat
immun
mesenter
lymph
node
effector
cell
testicl
cell
target
cell
collect
calf
time
surgeri
peritoneum
overli
mesenter
lymph
node
incis
node
isol
surround
fat
blunt
dissect
piec
node
x
cm
sharpli
excis
scissor
place
rpmi
contain
x
mercaptoethanol
fetal
bovin
serum
fb
penicillinstreptomycinfungizon
iu
gml
respect
node
cut
small
piec
tritur
metal
mesh
glass
pestl
lymphocyt
wash
twice
rpmi
maintain
rpmi
differ
concentr
concanavalin
gml
mesenter
lymphocyt
use
within
collect
one
testicl
surgic
remov
calf
establish
autolog
calf
testicl
cell
cultur
briefli
testicl
wash
hank
balanc
salt
solut
hbss
ph
tunica
albuginea
incis
mass
seminifer
tubul
remov
cut
small
piec
trypsin
h
room
temperatur
seminifer
tubul
isol
cell
centrifug
wash
twice
hbss
x
antibiot
cell
suspend
dulbecco
minimum
essenti
medium
fb
incub
day
autolog
system
use
ctl
assay
testicl
cell
lymphocyt
calf
experi
perform
mhcrestrict
ctl
assay
autolog
testicular
cell
infect
attenu
bcv
differ
multipl
infect
moi
differ
time
postinfect
target
cell
label
amersham
arlington
height
per
x
cell
water
bath
cell
wash
twice
rpmi
contain
fb
reincub
min
effector
e
cell
mix
target
cell
variou
ratio
e
follow
incub
h
test
done
quadrupl
flat
bottom
tissu
cultur
plate
nunclon
nunc
denmark
end
incub
plate
centrifug
supernat
pipet
triton
simultan
measur
case
spontan
lysi
maximum
lysi
percentag
specif
lysi
calcul
accord
follow
formula
percent
specif
lysi
maximum
releas
spontan
releas
experiment
releas
spontan
releas
x
blood
mix
equal
volum
hbss
care
layer
ficollhypaqu
sp
gr
centrifug
g
min
room
temperatur
peripher
blood
leukocyt
resuspend
normal
goat
serum
place
ice
h
block
nonspecif
bind
site
cell
centrifug
g
min
resuspend
ill
phosphat
buffer
salin
ph
monoclon
antibodi
bovin
lymphocyt
surfac
marker
obtain
dr
cindi
baldwin
intern
laboratori
research
anim
diseas
nairobi
kenya
ila
thtd
ila
tct
cell
incub
monoclon
antibodi
ice
h
centrifug
min
pellet
ad
fluorescein
conjug
goat
antimous
igg
follow
incub
ice
min
wash
cell
uniformli
suspend
glycerolpb
ph
examin
fluoresc
microscopi
cell
fine
green
surfac
fluoresc
count
total
number
cell
also
count
calcul
cell
belong
particular
cell
subset
least
cell
count
experi
calcul
subset
popul
mhcrestrict
cytotox
lymphocyt
test
use
autolog
testicular
cell
target
mesenter
lymphocyt
effector
percent
specif
lysi
calv
less
consid
neg
nonsignific
lymphocyt
calf
inocul
attenu
bcv
show
specif
lysi
week
infect
show
specif
lysi
week
infect
calv
inocul
virul
bcv
calf
show
specif
lysi
week
postinfect
respect
calf
show
specif
lysi
interv
studi
calf
show
specif
lysi
week
infect
uninfect
control
calv
show
specif
lysi
interv
studi
differ
specif
lysi
among
variou
group
calv
signific
time
interv
even
incorpor
iuml
recombin
bovin
american
cyanamid
princeton
nj
increas
specif
lysi
although
caus
increas
count
per
minut
cpm
parallel
increas
observ
spontan
lysi
indic
percent
specif
lysi
remain
cell
subset
tct
thtd
enumer
indirect
fluoresc
antibodi
test
use
antibodi
lymphocyt
surfac
marker
calf
infect
virul
bcv
number
tct
popul
decreas
infect
day
postinfect
fig
addit
calf
experienc
decreas
thto
popul
compar
control
attenu
virusinocul
calv
fig
histopatholog
examin
mesenter
lymph
node
calv
inocul
virul
viru
sever
deplet
lymphocyt
notic
peyer
patch
mesenter
lymph
node
compar
uninfect
control
virusspecif
mhcrestrict
ctl
activ
demonstr
calv
inocul
either
virul
attenu
bcv
indic
either
calv
ctl
activ
low
detect
techniqu
use
studi
low
amount
ctl
activ
observ
may
due
low
number
virusspecif
ctl
low
lytic
activ
ctl
administr
cephalosporin
done
studi
shown
suppress
gener
virusspecif
ctl
mice
theileria
parva
protozoan
infect
cattl
frequenc
precursor
one
attempt
made
clone
ctl
increas
autolog
testicular
cell
use
target
cell
studi
may
express
mhc
howev
attempt
made
demonstr
lack
mhc
previou
studi
bovin
testicular
cell
report
less
sensit
target
cell
possibl
intraepitheli
lymphocyt
iel
may
develop
ctl
activ
directli
expos
bcv
intestin
lumen
recent
studi
nonmhc
restrict
cytotox
activ
bcv
found
iel
peripher
blood
lymphocyt
bcvinfect
calv
studi
need
prove
disprov
hypothes
neg
ctl
result
obtain
studi
agreement
publish
report
anim
coronavirus
exampl
ctl
activ
transmiss
gastroenter
coronaviru
pig
caus
nont
cell
also
mous
hepat
viru
mhv
coronaviru
mice
ctl
activ
seen
mesenter
lymphocyt
associ
nklike
cell
present
iel
true
ctl
activ
howev
associ
tct
subpopul
paradox
bcvinfect
calv
develop
antibcv
antibodi
acut
phase
infect
bulk
antibcv
activ
associ
igm
may
direct
independ
antigen
glycoprotein
bcv
thu
acut
phase
bcvinfect
calv
develop
high
level
antibodi
chronic
phase
immunosuppress
calv
infect
virul
bcv
mesenter
lymph
node
peyer
patch
show
deplet
lymphocyt
agreement
previou
studi
mechan
bcv
caus
deplet
lymphocyt
known
appear
due
replic
bcv
cell
similar
find
report
mhv
